Sample size in clinical research: why it matters and how it is determined

Authors

  • Nitin Chandurkar Department of Clinical Research and Development, Ipca Laboratories Ltd. Mumbai, Maharashtra, India
  • Kumar Naidu Department of Clinical Research and Development, Ipca Laboratories Ltd. Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3259.ijct20262512

Keywords:

Sample size, Clinical trials, Biostatistics, Power, Variability, Study design

Abstract

Sample size is a critical component of clinical research that directly influences the validity, reliability, and interpretability of study findings. Determining an appropriate sample size is not merely a statistical exercise but a multidisciplinary decision involving clinical relevance, study design, variability, and ethical considerations. An inadequately powered study may fail to detect meaningful treatment effects, whereas an excessively large study may expose unnecessary numbers of participants to interventions and increase study costs. This article provides a practical overview of why sample size matters in clinical research and explains the major factors that influence its determination. Examples from different study settings, including superiority, non-inferiority, and bioequivalence studies, are used to bridge statistical concepts with practical application. Common misconceptions surrounding sample size are also discussed to improve understanding among clinical research professionals.

References

Chow SC, Shao J, Wang H, Lokhnygina Y. Sample Size Calculations in Clinical Research. 3rd ed. Boca Raton, FL: CRC Press; 2017: 1–510.

Julious SA. Sample Sizes for Clinical Trials. Boca Raton, FL: CRC Press; 2009: 1–358.

Friedman LM, Furberg CD, DeMets DL, Reboussin DM, Granger CB. Fundamentals of Clinical Trials. 5th ed. Cham: Springer International Publishing; 2015: 1–560.

Piantadosi S. Clinical Trials: A Methodologic Perspective. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2017: 1–816.

Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988: 1–567.

Pocock SJ. Clinical Trials: A Practical Approach. Chichester: John Wiley & Sons; 1983: 1–266.

ICH E9 Expert Working Group. Statistical Principles for Clinical Trials. 1998. Available at: https://www.ema.europa.eu/en/ich-e9-statistical-principles-clinical-trials-scientific-guideline. Accessed on 3 June 2026.

Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4(4):287-91.

Machin D, Campbell MJ, Tan SB, Tan SH. Sample Size Tables for Clinical Studies. 3rd ed. Wiley-Blackwell. 2009.

European Medicines Agency. Guideline on the Investigation of Bioequivalence. 2010. Available at: https://www.ema.europa.eu/en/investigation-bioequivalence-scientific-guideline. Accessed on 3 June 2026.

Downloads

Published

2026-07-28

How to Cite

Chandurkar, N., & Naidu, K. (2026). Sample size in clinical research: why it matters and how it is determined. International Journal of Clinical Trials, 13(3), 363–367. https://doi.org/10.18203/2349-3259.ijct20262512